214  Total SME IPOs listed in 2025

9,804.70 Crs.  Total funds raised in 2025

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

214  Total SME IPOs listed in 2025

9,804.70 Crs.  Total funds raised in 2025

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

214  Total SME IPOs listed in 2025

9,804.70 Crs.  Total funds raised in 2025

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

214  Total SME IPOs listed in 2025

9804.70 Crs.  Total funds raised in 2,025.00

145  SME IPOs listed with Gain in 2025

69  SME IPOs listed with loss in 2025

Onyx Biotec IPO (Onyx Biotec Limited IPO) Detail

Onyx Biotec Limited is an Pharmaceutical based company, located in Solan, Onyx Biotec Limited IPO size was 29.34 Cr. and was issued at 61.00 per share. The share of Onyx Biotec Limited were listed at 56.75 per share and are currently trading at 41.50 per share.

Type :
Sub Sector : Pharmaceutical Company Providing Sterile Water For Injections
SME IPO
NSE EMERGE

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
63.24 Cr.

PAT :
7.80 Cr.

Pricing Report

Issue Price :
61.00

Listing Price :
56.75

Current Market Price :
41.50

Issue Price vs CMP :
19.5 (31.97%)

listing Price vs CMP :
15.25 (26.87%)

Performance Report (CAGR* wise)

CAGR : -35.38
-ve 0 6 9 12+
Below Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About Onyx Biotec

Company Information
Onyx started its operation in pharmaceutical industry with sterile water for injections in the year 2010. Since then, Onyx has been associated with the healthcare segment and offering Sterile Pharmaceutical products and has become a prominent supplier of sterile products to major corporations, which includes the top pharma companies at pan India level. Onyx is committed to provide high-quality products at affordable price. Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas. Their products are being processed and manufactured in accordance with best FDA practices available globally. Their system and product is tested constantly at each level to ensure international standards of quality in-house
Show More
Object of Issue
  • Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use
  • Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections
  • Prepayment or repayment of all or a portion of certain loans availed by the Company and
  • General Corporate Purposes

Onyx Biotec SME IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Nov, 2024
IPO Size :
29.34 Cr.
Market Cap :
110.61 Cr.   
IPO Subscription :
198.00 X     
PE Multiple :
14.10
IPO Registrar:
Mas Services Limited
Anchor Investors:
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other SME IPOs in Solan

Shlokka Dyes Limited

  Manufacturing of reactive dyes and pigments

  Bharuch


Greenleaf Envirotech Limited

  Providing engineering, procurement, construction (EPC) and turnkey solutions for Wastewater Treatment Projects (WWT)

  Surat


DSM Fresh Foods Limited

  Fresh meat and ready-to-cook/eat non-veg products retailer

  New Delhi


Munish Forge Limited

  Manufacturing premium forged and cast components

  Ludhiana


Sheel Biotech Limited

  Business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants

  New Delhi


Peer Companies Of This Sector

FAQs

Onyx Biotec operates in Pharmaceutical and Pharmaceutical Company Providing Sterile Water For Injections. The Issue is listed on NSE EMERGE in Nov, 2024. Onyx Biotec IPO size was 29.34 Cr. with Issue price of 61.00 .

Onyx Biotec IPO subscription was 198.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Onyx Biotec IPO listed at a listing price of 56.75 against the offer price of 61.00.

The current market price of Onyx Biotec is 41.50.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency